Stage 3 Chronic Kidney Disease: Clinical Trials

3 trials for Stage 3 Chronic Kidney Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 11Completed 1
Phase 21Completed 1

Follow Stage 3 Chronic Kidney Disease: new trials by email Literature Review of Stage 3 Chronic Kidney Disease trials Research Report on Stage 3 Chronic Kidney Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lifestyle Intervention and Its Effects on Inflammatory Cytokines and Oxidative Stress Markers in Diabetic Chronic Kidney Disease Patients: A Randomized Controlled Trial
Lifestyle Modification (Exercise + Diet) - Type 2 Diabetes Mellitus, Inflammation, Chronic Low-Grade
Not applicableCompletedSinai University602025-03-012025-08-17
Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney Disease
CTP-499, placebo - Stage 3 Chronic Kidney Disease
Phase 1CompletedConcert Pharmaceuticals332011-08-012013-05-24
Fu-zheng-qu-zhuo Oral Liquid Improves Renal Function in Patients of CKD Stage 3 and 4
Fu-zheng-qu-zhuo (FZQZ) oral liquid - Stage 3 Chronic Kidney Disease, Stage 4 Chronic Kidney Disease
Phase 2CompletedGuang'anmen Hospital of China Academy of Chinese Medical Sciences1242010-06-012014-10-27

Narrower conditions

Renal Insufficiency, Chronic (3)  ·  Diabetes Mellitus, Type 2 (1)  ·  Inflammation (1)

Broader conditions

Chronic Disease (3)  ·  Disease Attributes (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Renal Insufficiency (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)

Interventions

1-(5-hydroxyhexyl)-3,7-dimethylxanthine (1)  ·  Diet (1)  ·  Exercise (1)  ·  Fluid Therapy (1)  ·  fu-zheng-qu-zhuo (1)

Sponsors

Concert Pharmaceuticals (1)  ·  Guang'anmen Hospital of China Academy of Chinese Medical Sciences (1)  ·  Sinai University (1)

Countries

China (1)  ·  Egypt (1)  ·  United States (1)

Top investigators

James Shipley, MD (1)  ·  Jie Wang (1)